You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and Japan Plasma Therapy Market Size, Status and Forecast 2021-2027

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.
Market Analysis and Insights: Global Plasma Therapy Market
The global Plasma Therapy market size is projected to reach US$ 480.4 million by 2027, from US$ 245.2 million in 2020, at a CAGR of 10.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasma Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasma Therapy market.
Plasma Therapy Breakdown Data by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
Plasma Therapy Breakdown Data by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
Based on regional and country-level analysis, the Plasma Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Plasma Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Plasma Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Plasma Therapy Market Perspective (2016-2027)
2.2 Plasma Therapy Growth Trends by Regions
2.2.1 Plasma Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plasma Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Plasma Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Plasma Therapy Industry Dynamic
2.3.1 Plasma Therapy Market Trends
2.3.2 Plasma Therapy Market Drivers
2.3.3 Plasma Therapy Market Challenges
2.3.4 Plasma Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Plasma Therapy Players by Revenue
3.1.1 Global Top Plasma Therapy Players by Revenue (2016-2021)
3.1.2 Global Plasma Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plasma Therapy Revenue
3.4 Global Plasma Therapy Market Concentration Ratio
3.4.1 Global Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Therapy Revenue in 2020
3.5 Plasma Therapy Key Players Head office and Area Served
3.6 Key Players Plasma Therapy Product Solution and Service
3.7 Date of Enter into Plasma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Plasma Therapy Breakdown Data by Type
4.1 Global Plasma Therapy Historic Market Size by Type (2016-2021)
4.2 Global Plasma Therapy Forecasted Market Size by Type (2022-2027)

5 Plasma Therapy Breakdown Data by Application
5.1 Global Plasma Therapy Historic Market Size by Application (2016-2021)
5.2 Global Plasma Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Plasma Therapy Market Size (2016-2027)
6.2 North America Plasma Therapy Market Size by Type
6.2.1 North America Plasma Therapy Market Size by Type (2016-2021)
6.2.2 North America Plasma Therapy Market Size by Type (2022-2027)
6.2.3 North America Plasma Therapy Market Size by Type (2016-2027)
6.3 North America Plasma Therapy Market Size by Application
6.3.1 North America Plasma Therapy Market Size by Application (2016-2021)
6.3.2 North America Plasma Therapy Market Size by Application (2022-2027)
6.3.3 North America Plasma Therapy Market Size by Application (2016-2027)
6.4 North America Plasma Therapy Market Size by Country
6.4.1 North America Plasma Therapy Market Size by Country (2016-2021)
6.4.2 North America Plasma Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Plasma Therapy Market Size (2016-2027)
7.2 Europe Plasma Therapy Market Size by Type
7.2.1 Europe Plasma Therapy Market Size by Type (2016-2021)
7.2.2 Europe Plasma Therapy Market Size by Type (2022-2027)
7.2.3 Europe Plasma Therapy Market Size by Type (2016-2027)
7.3 Europe Plasma Therapy Market Size by Application
7.3.1 Europe Plasma Therapy Market Size by Application (2016-2021)
7.3.2 Europe Plasma Therapy Market Size by Application (2022-2027)
7.3.3 Europe Plasma Therapy Market Size by Application (2016-2027)
7.4 Europe Plasma Therapy Market Size by Country
7.4.1 Europe Plasma Therapy Market Size by Country (2016-2021)
7.4.2 Europe Plasma Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Plasma Therapy Market Size (2016-2027)
8.2 Asia-Pacific Plasma Therapy Market Size by Type
8.2.1 Asia-Pacific Plasma Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plasma Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plasma Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Plasma Therapy Market Size by Application
8.3.1 Asia-Pacific Plasma Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plasma Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plasma Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Plasma Therapy Market Size by Region
8.4.1 Asia-Pacific Plasma Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plasma Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Plasma Therapy Market Size (2016-2027)
9.2 Latin America Plasma Therapy Market Size by Type
9.2.1 Latin America Plasma Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Plasma Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Plasma Therapy Market Size by Type (2016-2027)
9.3 Latin America Plasma Therapy Market Size by Application
9.3.1 Latin America Plasma Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Plasma Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Plasma Therapy Market Size by Application (2016-2027)
9.4 Latin America Plasma Therapy Market Size by Country
9.4.1 Latin America Plasma Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Plasma Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Plasma Therapy Market Size (2016-2027)
10.2 Middle East & Africa Plasma Therapy Market Size by Type
10.2.1 Middle East & Africa Plasma Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plasma Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plasma Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Plasma Therapy Market Size by Application
10.3.1 Middle East & Africa Plasma Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plasma Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plasma Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Plasma Therapy Market Size by Country
10.4.1 Middle East & Africa Plasma Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plasma Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Terumo
11.1.1 Terumo Company Details
11.1.2 Terumo Business Overview
11.1.3 Terumo Plasma Therapy Introduction
11.1.4 Terumo Revenue in Plasma Therapy Business (2016-2021)
11.1.5 Terumo Recent Development
11.2 Arthrex
11.2.1 Arthrex Company Details
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Plasma Therapy Introduction
11.2.4 Arthrex Revenue in Plasma Therapy Business (2016-2021)
11.2.5 Arthrex Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Plasma Therapy Introduction
11.3.4 Zimmer Biomet Revenue in Plasma Therapy Business (2016-2021)
11.3.5 Zimmer Biomet Recent Development
11.4 DePuy Synthes
11.4.1 DePuy Synthes Company Details
11.4.2 DePuy Synthes Business Overview
11.4.3 DePuy Synthes Plasma Therapy Introduction
11.4.4 DePuy Synthes Revenue in Plasma Therapy Business (2016-2021)
11.4.5 DePuy Synthes Recent Development
11.5 EmCyte
11.5.1 EmCyte Company Details
11.5.2 EmCyte Business Overview
11.5.3 EmCyte Plasma Therapy Introduction
11.5.4 EmCyte Revenue in Plasma Therapy Business (2016-2021)
11.5.5 EmCyte Recent Development
11.6 Regen Lab
11.6.1 Regen Lab Company Details
11.6.2 Regen Lab Business Overview
11.6.3 Regen Lab Plasma Therapy Introduction
11.6.4 Regen Lab Revenue in Plasma Therapy Business (2016-2021)
11.6.5 Regen Lab Recent Development
11.7 ISTO Biologics
11.7.1 ISTO Biologics Company Details
11.7.2 ISTO Biologics Business Overview
11.7.3 ISTO Biologics Plasma Therapy Introduction
11.7.4 ISTO Biologics Revenue in Plasma Therapy Business (2016-2021)
11.7.5 ISTO Biologics Recent Development
11.8 Cesca Therapeutics
11.8.1 Cesca Therapeutics Company Details
11.8.2 Cesca Therapeutics Business Overview
11.8.3 Cesca Therapeutics Plasma Therapy Introduction
11.8.4 Cesca Therapeutics Revenue in Plasma Therapy Business (2016-2021)
11.8.5 Cesca Therapeutics Recent Development
11.9 Weigao
11.9.1 Weigao Company Details
11.9.2 Weigao Business Overview
11.9.3 Weigao Plasma Therapy Introduction
11.9.4 Weigao Revenue in Plasma Therapy Business (2016-2021)
11.9.5 Weigao Recent Development
11.10 REV-MED
11.10.1 REV-MED Company Details
11.10.2 REV-MED Business Overview
11.10.3 REV-MED Plasma Therapy Introduction
11.10.4 REV-MED Revenue in Plasma Therapy Business (2016-2021)
11.10.5 REV-MED Recent Development
11.11 Nuo Therapeutics
11.11.1 Nuo Therapeutics Company Details
11.11.2 Nuo Therapeutics Business Overview
11.11.3 Nuo Therapeutics Plasma Therapy Introduction
11.11.4 Nuo Therapeutics Revenue in Plasma Therapy Business (2016-2021)
11.11.5 Nuo Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140